Cellectar Biosciences, Inc. - Common Stock — 財務諸表 (NASDAQ:CLRB) | MetaTrader

チャート全体を表示 Full chart

ニュース

Cellectar Biosciences, Inc. (CLRB) Q1 2026 Earnings Call Transcript

Cellectar Biosciences (CLRB) Upgraded to Buy: Here's What You Should Know

Has Centene (CNC) Outpaced Other Medical Stocks This Year?

Why Bark Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Abivax (NASDAQ:ABVX), Rich Sparkle Holdings (NASDAQ:ANPA)

Cellectar secures multi-year supply of alpha-emitting radioisotopes

セレクター・バイオサイエンス株、FDAが小児希少疾病指定を付与し急騰

FDAがセレクターのがん治療薬に希少小児疾患指定を付与

Cellectar Biosciences stock soars after FDA grants rare pediatric designation

FDA grants rare pediatric drug designation to Cellectar’s cancer therapy

セレクターの実験的がん治療薬、膵臓モデルで有望な結果を示す

Cellectar’s experimental cancer drug shows promise in pancreatic models

セレクター・バイオサイエンス、ワラント行使と新たな誘導ワラントで580万ドル調達